Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial

IMPORTANCE: Coronavirus disease 2019 (COVID-19) is associated with severe lung damage. Corticosteroids are a possible therapeutic option. OBJECTIVE: To determine the effect of hydrocortisone on treatment failure on day 21 in critically ill patients with severe acute respiratory syndrome coronavirus...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA
Glavni autori: Dequin, Pierre-François, Heming, Nicholas, Meziani, Ferhat, Plantefève, Gaëtan, Voiriot, Guillaume, Badié, Julio, François, Bruno, Aubron, Cécile, Ricard, Jean-Damien, Ehrmann, Stephan, Jouan, Youenn, Guillon, Antoine, Leclerc, Marie, Coffre, Carine, Bourgoin, Hélène, Lengellé, Céline, Caille-Fénérol, Caroline, Tavernier, Elsa, Zohar, Sarah, Giraudeau, Bruno, Annane, Djillali, Le Gouge, Amélie
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489432/
https://ncbi.nlm.nih.gov/pubmed/32876689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.16761
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items